Federica Girolami

Economic Evaluation of a New Antiemetic Drug — Palonosetron versus Ondansetron

R. Tarricone, Federica Girolami, 2005, Clinical drug investigation.

Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties

L. Rovati, F. Girolami, S. Persiani, 2012, Therapeutic advances in musculoskeletal disease.

Crystalline Glucosamine Sulfate in the Treatment of Osteoarthritis: Evidence of Long-Term Cardiovascular Safety from Clinical Trials

L. Rovati, G. Giacovelli, A. Bonazzi, 2011, The open rheumatology journal.

Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.

M. D'Amato, L. Rovati, G. Giacovelli, 2016, Seminars in arthritis and rheumatism.

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19

P. Ascierto, F. Palombo, A. Manenti, 2022, Molecular Therapy.

Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial.

M. D'Amato, L. Rovati, G. Giacovelli, 2019, Osteoarthritis and cartilage.